ФАРМАКОТЕРАПИЯ ОБОСТРЕНИЯ ХРОНИЧЕСКОГО ПИЕЛОНЕФРИТА В КЛИНИЧЕСКОЙ ПРАКТИКЕ

  • Published on
    05-Apr-2017

  • View
    216

  • Download
    0

Embed Size (px)

Transcript

  • BulletinofMedicalInternetConferences(ISSN22246150) 2013.Volume3.Issue2

    www.medconfer.com BulletinofMedicalInternetConferences,2013

    386

    ID:201302213T2381 ..

    .,

    :..

    .

    0,81,51000..

    ..3..

    146..14655,5%

    44,5%. 65%, 35%

    . 4 27 , 8,7.

    98%,2%. .

    85,6%,14,4%. . 100%.27(18,5%). : staphylococcus aureus14,8%, enterobacter spp.11,1%, scherichia coli29,6%, streptococcusfaecalis3,7%,acinetobacterspp18,5%,pseudomonasaeruginosa18,5%,providenciarettgeri3,7%.

    51,2%21,6%.22 IIII (17,6%). 4%,3,2%,1,6%0,8%.

    ..

    .

    ,

Recommended

View more >